|
1
|
Thomas-MacLean R: Beyond dichotomies of
health and illness: Life after breast cancer. Nurs Inq. 12:200–209.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roje Z, Roje Z, Janković S and Ninković M:
Breast reconstruction after mastectomy. Coll Antropol. 34 Suppl
1:S113–S123. 2010.
|
|
3
|
Rozen WM, Rajkomar AK, Anavekar NS and
Ashton MW: Post-mastectomy breast reconstruction: A history in
evolution. Clin Breast Cancer. 9:145–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Djohan R, Gage E and Bernard S: Breast
reconstruction options following mastectomy. Cleve Clin J Med. 75
Suppl 1:S17–S23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Techanukul T and Lohsiriwat V: Stem cell
and tissue engineering in breast reconstruction. Gland Surg.
3:55–61. 2014.PubMed/NCBI
|
|
6
|
Holland MS and Holland RE: The cellular
perspective on mammary gland development: Stem/progenitor cells and
beyond. J Dairy Sci. 88 Suppl 1:E1–E8. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deome KB, Faulkin LJ Jr, Bern HA and Blair
PB: Development of mammary tumors from hyperplastic alveolar
nodules transplanted into gland-free mammary fat pads of female C3H
mice. Cancer Res. 19:515–520. 1959.PubMed/NCBI
|
|
8
|
Ercan C, van Diest PJ and Vooijs M:
Mammary development and breast cancer: The role of stem cells. Curr
Mol Med. 11:270–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: Mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L and Neaves WB: Normal stem cells and
cancer stem cells: The niche matters. Cancer Res. 66:4553–4557.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Liu Q and Song E: Mammary stem
cells: Angels or demons in mammary gland? Signal Transduction
Targeted Therapy. 2:160382017. View Article : Google Scholar
|
|
12
|
Kao CY, Nomata K, Oakley CS, Welsch CW and
Chang CC: Two types of normal human breast epithelial cells derived
from reduction mammoplasty: Phenotypic characterization and
response to SV40 transfection. Carcinogenesis. 16:531–538. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ponti D, Zaffaroni N, Capelli C and
Daidone MG: Breast cancer stem cells: An overview. Eur J Cancer.
42:1219–1224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shackleton M, Vaillant F, Simpson KJ,
Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ and
Visvader JE: Generation of a functional mammary gland from a single
stem cell. Nature. 439:84–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stingl J, Eirew P, Ricketson I, Shackleton
M, Vaillant F, Choi D, Li HI and Eaves CJ: Purification and unique
properties of mammary epithelial stem cells. Nature. 439:993–997.
2006.PubMed/NCBI
|
|
16
|
Proia DA and Kuperwasser C: Reconstruction
of human mammary tissues in a mouse model. Nat Protoc. 1:206–214.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalirai H and Clarke RB: Human breast
epithelial stem cells and their regulation. J Pathol. 208:7–16.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gudjonsson T, Villadsen R, Nielsen HL,
Ronnov-Jessen L, Bissell MJ and Petersen OW: Isolation,
immortalization, and characterization of a human breast epithelial
cell line with stem cell properties. Genes Dev. 16:693–706. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Slaughter DP, Southwick HW and Smejkal W:
Field cancerization in oral stratified squamous epithelium;
clinical implications of multicentric origin. Cancer. 6:963–968.
1953. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Försti A, Louhelainen J, Söderberg M,
Wijkström H and Hemminki K: Loss of heterozygosity in
tumour-adjacent normal tissue of breast and bladder cancer. Eur J
Cancer. 37:1372–1380. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klevebring D, Rosin G, Ma R, Lindberg J,
Czene K, Kere J, Fredriksson I, Bergh J and Hartman J: Sequencing
of breast cancer stem cell populations indicates a dynamic
conversion between differentiation states in vivo. Breast Cancer
Res. 16:R722014. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morroni M, Giordano A, Zingaretti MC,
Boiani R, De Matteis R, Kahn BB, Nisoli E, Tonello C, Pisoschi C,
Luchetti MM, et al: Reversible transdifferentiation of secretory
epithelial cells into adipocytes in the mammary gland. Proc Natl
Acad Sci USA. 101:pp. 16801–16806. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Matteis R, Zingaretti MC, Murano I,
Vitali A, Frontini A, Giannulis I, Barbatelli G, Marcucci F,
Bordicchia M, Sarzani R, et al: In vivo physiological
transdifferentiation of adult adipose cells. Stem Cells.
27:2761–2768. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mammary stem cells and the differentiation
hierarchy: Current status and perspectives. Genes Dev.
28:1143–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burkhart DL and Sage J: Cellular
mechanisms of tumour suppression by the retinoblastoma gene. Nat
Rev Cancer. 8:671–682. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blanco-Aparicio C, Renner O, Leal JF and
Carnero A: PTEN, more than the AKT pathway. Carcinogenesis.
28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luthy IA, Bruzzone A, Piñero CP, Castillo
LF, Chiesa IJ, Vázquez SM and Sarappa MG: Adrenoceptors: Non
conventional target for breast cancer? Curr Med Chem. 16:1850–1862.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Caldon CE, Daly RJ, Sutherland RL and
Musgrove EA: Cell cycle control in breast cancer cells. J Cell
Biochem. 97:261–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Walia V, Ding M, Kumar S, Nie D, Premkumar
LS and Elble RC: hCLCA2 Is a p53-Inducible Inhibitor of Breast
Cancer Cell Proliferation. Cancer Res. 69:6624–6632. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hitchler MJ, Oberley LW and Domann FE:
Epigenetic silencing of SOD2 by histone modifications in human
breast cancer cells. Free Radic Biol Med. 45:1573–1580. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pratt MA, Tibbo E, Robertson SJ, Jansson
D, Hurst K, Perez-Iratxeta C, Lau R and Niu MY: The canonical
NF-kappaB pathway is required for formation of luminal mammary
neoplasias and is activated in the mammary progenitor population.
Oncogene. 28:2710–2722. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Margheri F, Serrati S, Lapucci A,
Anastasia C, Giusti B, Pucci M, Torre E, Bianchini F, Calorini L,
Albini A, et al: Systemic sclerosis-endothelial cell antiangiogenic
pentraxin 3 and matrix metalloprotease 12 control human breast
cancer tumor vascularization and development in mice. Neoplasia.
11:1106–1115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pontier SM and Muller WJ: Integrins in
mammary-stem-cell biology and breast-cancer progression-a role in
cancer stem cells? J Cell Sci. 122:207–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A,
Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, et al:
Expression of interleukin-1beta in human breast carcinoma. Cancer.
80:421–434. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Freudenberg JA, Wang Q, Katsumata M,
Drebin J, Nagatomo I and Greene MI: The role of HER2 in early
breast cancer metastasis and the origins of resistance to
HER2-targeted therapies. Exp Mol Pathol. 87:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moon A: Differential functions of Ras for
malignant phenotypic conversion. Arch Pharm Res. 29:113–122. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jamerson MH, Johnson MD and Dickson RB: Of
mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol
Neoplasia. 9:27–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stoelzle T, Schwarb P, Trumpp A and Hynes
NE: c-Myc affects mRNA translation, cell proliferation and
progenitor cell function in the mammary gland. BMC Biol. 7:632009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Garderen E and Schalken JA:
Morphogenic and tumorigenic potentials of the mammary growth
hormone/growth hormone receptor system. Mol Cell Endocrinol.
197:153–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirohata S, Wang LW, Miyagi M, Yan L,
Seldin MF, Keene DR, Crabb JW and Apte SS: Punctin, a novel
ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J Biol
Chem. 277:12182–12189. 2002. View Article : Google Scholar : PubMed/NCBI
|
